ECO Animal Health Group’s (EAH) “Buy” Rating Reiterated at Shore Capital

Shore Capital reiterated their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note released on Monday, Marketbeat.com reports. They currently have a GBX 150 target price on the stock.

ECO Animal Health Group Stock Performance

LON EAH opened at GBX 83.02 on Monday. The stock has a market capitalization of £56.03 million, a price-to-earnings ratio of 34.16 and a beta of -0.05. The stock has a 50-day moving average of GBX 82.26 and a 200 day moving average of GBX 70.11. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. ECO Animal Health Group has a twelve month low of GBX 50 and a twelve month high of GBX 100.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.